Pharmacies & Pharmacists Targeted in DEA Diversion Investigations: Legal Actions to Take
An Immediate Suspension Order can shut down a pharmacy’s ability to dispense controlled substances on the same day it is signed, under 21 U.S.C. § 824(d). There is no hearing first, no advance warning. The DEA only needs to find an “imminent danger to public health or safety”, and the registration will be suspended until the case goes through an administrative process which can take months. For pharmacists or pharmacy owners, this single order can freeze their business, trigger a state board investigation, and lead to a criminal investigation.
How DEA Diversion Investigations Start
Most diversion cases do not begin with a raid. They begin with data patterns. The DEA’s ARCOS system tracks controlled substances orders from manufacturers to pharmacies, and unusual purchase volumes flag a pharmacy for closer review. This is especially true for oxycodone, hydrocodone and other Schedule II drugs. A board of pharmacy complaint, a former employee’s report or even a tip from a competing pharmacy can start the process.Federal Rule of Criminal Procedure 11(c). Like any contract, both sides give up something. The government typically agrees to drop certain charges, recommend a particular sentence, or both. The defendant agrees to plead guilty and waives specific rights.
Once DEA has a reason to investigate, it typically issues an administrative subpoena under 21 U.S.C. § 876 for dispensing records, purchasing history, and prescribing patterns. Responding to such a subpoena is not the same as being actively targeted. However, it is also not something that should be treated casually. Some subpoenas are merely routine compliance checks, while others are the opening moves in cases that have been building for months, and the distinction is often not apparent from the documents themselves.
What’s at Stake: Administrative, Civil, and Criminal Exposure
The DEA has two tools for stopping a registrant that it believes is out of compliance: an Order to Show Cause, which starts a formal process, while the pharmacy generally continues operating, and an Immediate Suspension Order, which stops operations in the event of imminent danger. These two are sometimes used together.
Recordkeeping failures under 21 CFR Part 1304 are the most common finding in these cases, and they carry their own civil exposure under the Controlled Substances Act, assessed per violation. That’s before criminal exposure is even considered.
On the criminal side, unlawful distribution or dispensation outside the usual course of professional practice may be charged under 21 U.S.C. § 841(a)(1). Providing false information in required records or applications is covered by 21 U.S.C. § 843(a)(4). When billing practices are also at issue, prosecutors may add healthcare fraud charges under 18 U.S.C. § 1347.
The collateral consequences often outlast the case itself. A state pharmacy board can open its own proceedings regardless of how the federal matter resolves, and the HHS Office of Inspector General can exclude a pharmacist from Medicare, Medicaid and every other federal healthcare program. This exclusion doesn’t require a criminal conviction to trigger and, for many pharmacists, it functions as a professional death sentence.
The First 48 Hours: What to Do When You Learn You’re Under Investigation
The first two days set the tone for everything that follows.
Preserve every record. Don’t delete files, don’t reorganize the pharmacy’s system, and don’t “clean up” dispensing logs. Altering records after learning about an investigation can turn a civil recordkeeping issue into an obstruction charge, which is often easier for the government to prove than the underlying diversion allegation.
Don’t talk to agents without a lawyer present. DEA investigators are trained interviewers, and an informal conversation can lead to statements that are difficult to retract later. It’s okay to be polite and refuse to answer questions until a lawyer is involved.
Call a lawyer immediately and notify the pharmacy’s professional liability insurance carrier the same day. Many policies have short notice deadlines and missing one can affect coverage for the defence itself.
Then start an internal review. Pull the prescriptions the DEA is likely to focus on: high volume, high morphine milligram equivalents, cash pay, or prescriber patterns that already look unusual internally. Get a clear picture of the file before the government presents its version of it.
Responding to an Order to Show Cause or Immediate Suspension Order
A registrant served with an order to show cause has the right to request a hearing before a DEA administrative law judge, typically within 30 days of receiving notice. Missing this deadline may waive the right to contest the decision at all.
Two paths short of a full hearing exist. A Memorandum of Agreement allows a pharmacy to accept specific compliance conditions in exchange for maintaining its registration. A corrective action plan directly addresses the government’s concerns and can sometimes prevent formal proceedings from starting
At that hearing, the DEA has to weigh public interest factors set out in 21 U.S.C. § 823(g)(1): a registrant’s compliance history, prior convictions, experience with dispensing controlled substances, and any findings from state boards. A pharmacy with a long, clean record and a single flagged period for ordering can look very different from one with documented patterns going back years.
Here’s the practical reality: even a pharmacy that eventually prevails against an immediate suspension order usually loses weeks or months of controlled substance business while the matter is pending. This disruption has to be planned for along with the legal defense, not after it. Staffing, cash flow, and patient transfers all need attention too, not just legal filings.
Building a Defense Strategy
Corresponding responsibility is a phrase that appears in almost every case of pharmacist diversion. Under 21 CFR § 1306.04, the pharmacist has an independent duty to address red flags on a prescription before filling it, independent of whatever the prescribing physician intended. This standard is where most defenses live or die.
An expert review of dispensing patterns often reveals that conduct deemed suspicious by the DEA was actually defensible, given accepted pharmacy practice for relevant drug classes, the patient population and geographic area, and what the pharmacist knew at the time.
Where criminal exposure runs parallel to an administrative case, they have to be carefully coordinated. Statements made to resolve an administrative matter quickly can become evidence in a later criminal trial. A defense built without this coordination can win a small fight but lose a larger one.
Why Prosecutorial Experience Matters in a Diversion Case
Aaron L. Wiley spent 18 years as an Assistant U.S. Attorney in the Northern District of Texas, where he built and evaluated cases of fraud and financial crimes that now appear on the other side of his desk. He knows what a prosecutor needs to make a case stronger and what a weak case looks like from inside.
That experience shapes how he evaluates the diversion investigation from day one: which allegations are likely to hold up, which are built on incomplete data, and where the case is actually heading before the government says so. Clients get in touch with him directly. He answers his phone and walks people through what’s happening at every stage.
Talk to a Former Federal Prosecutor Directly
Many pharmacists who face DEA diversion investigations are dealing with the federal system for the first time, and the process is designed to move faster than most people can absorb. Aaron L. Wiley has spent his career on both sides of these cases. He started building them as a federal prosecutor, and now he defends them. He answers the phone himself, goes through what the government alleges, and lays out realistic options before any decision is made.
If your pharmacy has received a subpoena, an order to show cause, or an immediate suspension order, contact us today.
FAQs
It’s an inquiry into whether controlled substances are being ordered, dispensed, or tracked outside of legitimate medical need. These investigations are often triggered by ARCOS ordering patterns, a Board of Pharmacy referral, or a complaint from an employee or competitor.
Yes. An Immediate Suspension Order under 21 U.S.C. § 824(d) becomes effective immediately, before any hearing, if the DEA finds an imminent threat to public health or safety.
No. Most recordkeeping issues are handled administratively or civilly. Criminal charges generally require evidence of intent, not just an error in a log.
It varies with the case and the complexity of the allegations, but contested cases typically take several months from the order to show cause to a final decision.
Under an Order to Show Cause, usually yes. Under an Immediate Suspension Order, registration is inactive until the case is resolved or the order is lifted.
Stay calm, confirm the agents’ credentials, and contact the owners and counsel immediately. Staff are not required to answer substantial questions on the spot.
